查詢結果分析
相關文獻
- Villoglandular Papillary Adenocarcinoma of the Uterine Cervix with Foci of Small Cell Carcinoma:A Case Report
- Survival Advantages and Complications of Adjuvant Therapy in Early-Stage Cervical Cancer with Pelvic Node Metastasis
- Clinincal Characteristics and Management of Enterovesical Fistulas
- Well-Differentiated Papillary Villoglandular Adenocarcinoma of the Uterine Cervix: A Case Report
- 以皮膚穴道電機能篩檢儀對婦科腫瘤病人治療前後及恢復期之觀察
- Implications of a Failed Prospective Trial of Adjuvant Therapy after Radical Hysterectomy for Stage Ib-IIa Cervical Carcinoma with Pelvic Node Metastases
- 推展婦女子宮頸癌防治工作策略與成果
- 子宮頸癌的化學治療
- SCC抗原於子宮頸癌臨床診治上的價值
- 靈芝水溶液對婦癌細胞生長之抑制效果
頁籤選單縮合
題 名 | Villoglandular Papillary Adenocarcinoma of the Uterine Cervix with Foci of Small Cell Carcinoma:A Case Report=子宮頸絨性腺癌合併小細胞癌:病例報告 |
---|---|
作 者 | 尹長生; 詹景全; 趙德彰; 鄭建睿; | 書刊名 | 中華民國婦產科醫學會會刊雜誌 |
卷 期 | 37:1 1998.03[民87.03] |
頁 次 | 頁21-26 |
分類號 | 417.2832 |
關鍵詞 | 子宮頸絨性腺癌; 小細胞癌; 子宮頸癌; Villoglandular adenocarcinoma; Small cell carcinoma; Uterine cervix; |
語 文 | 英文(English) |
中文摘要 | 背景:子宮頸絨性腺癌是一種非少見之腺癌。到目前為止,僅有49例的文獻 報告。本症的預後通常較上皮癌為佳,可用保守性手術治療。患者多為30 歲之女性,但一旦有淋巴轉移或合併有小細胞癌、漿細胞癌及透明細胞癌 時,預後較上皮癌為差,在診治方面必須注意。 病例報告:我們發現一位52歲停經後之婦女因子宮頸絨性併生小細胞癌腺癌,行子 宮根除手術及淋巴腺、主動脈旁淋巴切除術。術後發現有子宮頸局部組織 之淋巴系有癌細胞侵犯癌,但沒有骨盆淋巴結及主動脈旁淋巴結轉移。術 後十個月追蹤病人,無異常發現。 結論:我們認為應注意此罕見病例之病理切片診斷,是否子宮頸有局部組織的淋 巴血管侵犯,併性低分化之細癌,盆腔淋巴轉移,再決定治療方針。本 例在接受根除手術及盆腔淋巴清除之預後仍須期追蹤檢查。 |
英文摘要 | Background:Villoglandular papillary adenocarcinoma of the uterine cervix is one of the variants of adenocarcinoma, and it has been reported to occur in relatively young women. The disease has a favorable prognosis if no lymphtic vascular invasion and no minor components such as small cell carcinoma, serous cell carcinoma, and clear cell carcinoma, are present, allowing a more conservative treatment to be undertaken. Until 1997, only 49 cases had been reported. Case report: A 52-year old womoan was diagnosed as having villoglandular papillary adenocarcinoma of the uterine cervix with small cell carcinoma components. She underwent a readical hysterectomy with pelvic lymphadenectomy and selective para-aortic lymph modes sampling. The pathological sections showed a predominantly villoglandular papillary growth with foci of small cell neuroendocrine carcinoma; no lymph node invasion was noted. At her 10-month follow-up examination, she was free of disease. Conclusion: The presence of minor components with this tumor (small cell carcinoma and lymphatic vascular invasion, in this case) suggests a poor prognosis. Radical surgery with extensive pelvic lymph node dissection should be performend in this type of situation. Close follow-up and more case reports are needed to confirm the efficacy of this treatment. |
本系統中英文摘要資訊取自各篇刊載內容。